{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T03:39:16Z","timestamp":1792640356204,"version":"4.5.0"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,7,27]],"date-time":"2026-07-27T00:00:00Z","timestamp":1785110400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T00:00:00Z","timestamp":1792627200000},"content-version":"vor","delay-in-days":87,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cancer"],"DOI":"10.1186\/s12885-026-16552-8","type":"journal-article","created":{"date-parts":[[2026,7,27]],"date-time":"2026-07-27T14:12:49Z","timestamp":1785161569000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["EIF3B is associated with m6A-related regulation of E2F7 and promotes stemness in glioblastoma multiforme"],"prefix":"10.1186","volume":"26","author":[{"given":"Jiao","family":"Meng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinyi","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yaling","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinyue","family":"Tian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhenkun","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhening","family":"Pu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Yin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,27]]},"reference":[{"issue":"6409","key":"16552_CR1","doi-asserted-by":"publisher","first-page":"1317","DOI":"10.1126\/science.aau3830","volume":"361","author":"M Song","year":"2018","unstructured":"Song M, Vogelstein B, Giovannucci EL, Willett WC, Tomasetti C. Cancer prevention: Molecular and epidemiologic consensus. Science. 2018;361(6409):1317\u20138.","journal-title":"Science"},{"issue":"3","key":"16552_CR2","first-page":"166","volume":"60","author":"EG Van Meir","year":"2010","unstructured":"Van Meir EG, Hadjipanayis CG, Norden AD, Shu HK, Wen PY, Olson JJ. Exciting new advances in neuro-oncology: the avenue to a cure for malignant glioma. CA Cancer J Clin. 2010;60(3):166\u201393.","journal-title":"CA Cancer J Clin"},{"issue":"10","key":"16552_CR3","doi-asserted-by":"publisher","first-page":"987","DOI":"10.1056\/NEJMoa043330","volume":"352","author":"R Stupp","year":"2005","unstructured":"Stupp R, Mason WP, van den Bent MJ, Weller M, Fisher B, Taphoorn MJ, Belanger K, Brandes AA, Marosi C, Bogdahn U, et al. Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med. 2005;352(10):987\u201396.","journal-title":"N Engl J Med"},{"issue":"7412","key":"16552_CR4","doi-asserted-by":"publisher","first-page":"522","DOI":"10.1038\/nature11287","volume":"488","author":"J Chen","year":"2012","unstructured":"Chen J, Li Y, Yu TS, McKay RM, Burns DK, Kernie SG, Parada LF. A restricted cell population propagates glioblastoma growth after chemotherapy. Nature. 2012;488(7412):522\u20136.","journal-title":"Nature"},{"issue":"6","key":"16552_CR5","doi-asserted-by":"publisher","first-page":"2462","DOI":"10.1016\/j.ymthe.2025.02.043","volume":"33","author":"P Poorva","year":"2025","unstructured":"Poorva P, Mast J, Cao B, Shah MV, Pollok KE, Shen J. Killing the killers: Natural killer cell therapy targeting glioma stem cells in high-grade glioma. Mol Ther. 2025;33(6):2462\u201378.","journal-title":"Mol Ther"},{"issue":"14","key":"16552_CR6","doi-asserted-by":"publisher","first-page":"1533","DOI":"10.1101\/gad.184911.111","volume":"26","author":"LA Carvajal","year":"2012","unstructured":"Carvajal LA, Hamard PJ, Tonnessen C, Manfredi JJ. E2F7, a novel target, is up-regulated by p53 and mediates DNA damage-dependent transcriptional repression. Genes Dev. 2012;26(14):1533\u201345.","journal-title":"Genes Dev"},{"issue":"5","key":"16552_CR7","doi-asserted-by":"publisher","first-page":"104677","DOI":"10.1016\/j.jbc.2023.104677","volume":"299","author":"ZQ Zheng","year":"2023","unstructured":"Zheng ZQ, Huang ZH, Liang YL, Zheng WH, Xu C, Li ZX, Liu N, Yang PY, Li YQ, Ma J, et al. VIRMA promotes nasopharyngeal carcinoma, tumorigenesis, and metastasis by upregulation of E2F7 in an m6A-dependent manner. J Biol Chem. 2023;299(5):104677.","journal-title":"J Biol Chem"},{"issue":"5","key":"16552_CR8","doi-asserted-by":"publisher","first-page":"e0321757","DOI":"10.1371\/journal.pone.0321757","volume":"20","author":"J Ma","year":"2025","unstructured":"Ma J, Xu R, Li R, Fu Y, Xu J, Zhou L, Qi Y. Integration of bioinformatics and identification of the role of m6A genes in NAFLD. PLoS ONE. 2025;20(5):e0321757.","journal-title":"PLoS ONE"},{"issue":"12","key":"16552_CR9","doi-asserted-by":"publisher","first-page":"1630","DOI":"10.7150\/ijbs.26932","volume":"14","author":"X Feng","year":"2018","unstructured":"Feng X, Li J, Liu P. The Biological Roles of Translation Initiation Factor 3b. Int J Biol Sci. 2018;14(12):1630\u20135.","journal-title":"Int J Biol Sci"},{"issue":"8","key":"16552_CR10","first-page":"7311","volume":"16","author":"R Huang","year":"2024","unstructured":"Huang R, Nie W, Mi L, Yao C, Zhu H. EIF3B stabilizes PCNA by counteracting SYVN1-mediated ubiquitination to serve as a promotor in cholangiocarcinoma. Aging. 2024;16(8):7311\u201330.","journal-title":"Aging"},{"issue":"11","key":"16552_CR11","doi-asserted-by":"publisher","first-page":"2850","DOI":"10.1158\/1078-0432.CCR-12-3084","volume":"19","author":"H Wang","year":"2013","unstructured":"Wang H, Ru Y, Sanchez-Carbayo M, Wang X, Kieft JS, Theodorescu D. Translation initiation factor eIF3b expression in human cancer and its role in tumor growth and lung colonization. Clin Cancer Res. 2013;19(11):2850\u201360.","journal-title":"Clin Cancer Res"},{"issue":"1","key":"16552_CR12","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1186\/s12943-019-1109-9","volume":"18","author":"L He","year":"2019","unstructured":"He L, Li H, Wu A, Peng Y, Shu G, Yin G. Functions of N6-methyladenosine and its role in cancer. Mol Cancer. 2019;18(1):176.","journal-title":"Mol Cancer"},{"issue":"3","key":"16552_CR13","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1016\/j.ccell.2020.02.004","volume":"37","author":"H Huang","year":"2020","unstructured":"Huang H, Weng H, Chen J. m(6)A Modification in Coding and Non-coding RNAs: Roles and Therapeutic Implications in Cancer. Cancer Cell. 2020;37(3):270\u201388.","journal-title":"Cancer Cell"},{"issue":"1","key":"16552_CR14","doi-asserted-by":"publisher","first-page":"2504","DOI":"10.1038\/s41467-018-04936-9","volume":"9","author":"J Jiao","year":"2018","unstructured":"Jiao J, Zhang R, Li Z, Yin Y, Fang X, Ding X, Cai Y, Yang S, Mu H, Zong D, et al. Nuclear Smad6 promotes gliomagenesis by negatively regulating PIAS3-mediated STAT3 inhibition. Nat Commun. 2018;9(1):2504.","journal-title":"Nat Commun"},{"issue":"6","key":"16552_CR15","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1038\/s41568-019-0143-7","volume":"19","author":"LN Kent","year":"2019","unstructured":"Kent LN, Leone G. The broken cycle: E2F dysfunction in cancer. Nat Rev Cancer. 2019;19(6):326\u201338.","journal-title":"Nat Rev Cancer"},{"issue":"12","key":"16552_CR16","doi-asserted-by":"publisher","first-page":"1203","DOI":"10.1101\/gad.261982.115","volume":"29","author":"JD Lathia","year":"2015","unstructured":"Lathia JD, Mack SC, Mulkearns-Hubert EE, Valentim CL, Rich JN. Cancer stem cells in glioblastoma. Genes Dev. 2015;29(12):1203\u201317.","journal-title":"Genes Dev"},{"issue":"12","key":"16552_CR17","doi-asserted-by":"publisher","first-page":"1054","DOI":"10.1016\/j.trecan.2021.08.005","volume":"7","author":"M Merchant","year":"2021","unstructured":"Merchant M, Ranjan A, Pang Y, Yu G, Kim O, Khan J, Wu J. Tumor mutational burden and immunotherapy in gliomas. Trends Cancer. 2021;7(12):1054\u20138.","journal-title":"Trends Cancer"},{"key":"16552_CR18","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/j.drup.2018.03.003","volume":"42","author":"F Sharifzad","year":"2019","unstructured":"Sharifzad F, Ghavami S, Verdi J, Mardpour S, Mollapour Sisakht M, Azizi Z, Taghikhani A, Los MJ, Fakharian E, Ebrahimi M, et al. Glioblastoma cancer stem cell biology: Potential theranostic targets. Drug Resist Updat. 2019;42:35\u201345.","journal-title":"Drug Resist Updat"},{"issue":"7","key":"16552_CR19","doi-asserted-by":"publisher","first-page":"1119","DOI":"10.1038\/cdd.2014.31","volume":"21","author":"B Auffinger","year":"2014","unstructured":"Auffinger B, Tobias AL, Han Y, Lee G, Guo D, Dey M, Lesniak MS, Ahmed AU. Conversion of differentiated cancer cells into cancer stem-like cells in a glioblastoma model after primary chemotherapy. Cell Death Differ. 2014;21(7):1119\u201331.","journal-title":"Cell Death Differ"},{"issue":"7120","key":"16552_CR20","doi-asserted-by":"publisher","first-page":"756","DOI":"10.1038\/nature05236","volume":"444","author":"S Bao","year":"2006","unstructured":"Bao S, Wu Q, McLendon RE, Hao Y, Shi Q, Hjelmeland AB, Dewhirst MW, Bigner DD, Rich JN. Glioma stem cells promote radioresistance by preferential activation of the DNA damage response. Nature. 2006;444(7120):756\u201360.","journal-title":"Nature"},{"issue":"7554","key":"16552_CR21","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1038\/nature14267","volume":"522","author":"AS Lee","year":"2015","unstructured":"Lee AS, Kranzusch PJ, Cate JH. eIF3 targets cell-proliferation messenger RNAs for translational activation or repression. Nature. 2015;522(7554):111\u20134.","journal-title":"Nature"},{"issue":"2","key":"16552_CR22","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1016\/j.molcel.2016.05.033","volume":"63","author":"A Simonetti","year":"2016","unstructured":"Simonetti A, Brito Querido J, Myasnikov AG, Mancera-Martinez E, Renaud A, Kuhn L, Hashem Y. eIF3 Peripheral Subunits Rearrangement after mRNA Binding and Start-Codon Recognition. Mol Cell. 2016;63(2):206\u201317.","journal-title":"Mol Cell"},{"issue":"1","key":"16552_CR23","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1186\/s12885-019-6071-9","volume":"19","author":"F Xu","year":"2019","unstructured":"Xu F, Zhang S, Liu Z, Gu J, Li Y, Wang L, Mao W, Zhu Q, Shou H, Ge D, et al. TEX9 and eIF3b functionally synergize to promote the progression of esophageal squamous cell carcinoma. BMC Cancer. 2019;19(1):875.","journal-title":"BMC Cancer"},{"issue":"5","key":"16552_CR24","doi-asserted-by":"publisher","first-page":"1057","DOI":"10.1007\/s10072-011-0894-8","volume":"33","author":"H Liang","year":"2012","unstructured":"Liang H, Ding X, Zhou C, Zhang Y, Xu M, Zhang C, Xu L. Knockdown of eukaryotic translation initiation factors 3B (EIF3B) inhibits proliferation and promotes apoptosis in glioblastoma cells. Neurol Sci. 2012;33(5):1057\u201362.","journal-title":"Neurol Sci"},{"key":"16552_CR25","doi-asserted-by":"crossref","unstructured":"Krassnig S, Wohlrab C, Golob-Schwarzl N, Raicht A, Schatz C, Birkl-Toeglhofer AM, Skofler C, Gantenbein N, Leoni M, Asslaber M et al. A Profound Basic Characterization of eIFs in Gliomas: Identifying eIF3I and 4H as Potential Novel Target Candidates in Glioma Therapy. Cancers (Basel). 2021;13(6):1482.","DOI":"10.3390\/cancers13061482"},{"issue":"6","key":"16552_CR26","doi-asserted-by":"publisher","first-page":"1262","DOI":"10.1111\/jcmm.12479","volume":"19","author":"I Olmez","year":"2015","unstructured":"Olmez I, Shen W, McDonald H, Ozpolat B. Dedifferentiation of patient-derived glioblastoma multiforme cell lines results in a cancer stem cell-like state with mitogen-independent growth. J Cell Mol Med. 2015;19(6):1262\u201372.","journal-title":"J Cell Mol Med"},{"issue":"1","key":"16552_CR27","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1186\/s13287-019-1283-0","volume":"10","author":"N Li","year":"2019","unstructured":"Li N, Li X, Chen K, Dong H, Kagami H. Characterization of spontaneous spheroids from oral mucosa-derived cells and their direct comparison with spheroids from skin-derived cells. Stem Cell Res Ther. 2019;10(1):184.","journal-title":"Stem Cell Res Ther"},{"issue":"12","key":"16552_CR28","doi-asserted-by":"publisher","first-page":"1403","DOI":"10.1038\/cr.2014.151","volume":"24","author":"X Zhao","year":"2014","unstructured":"Zhao X, Yang Y, Sun BF, Shi Y, Yang X, Xiao W, Hao YJ, Ping XL, Chen YS, Wang WJ, et al. FTO-dependent demethylation of N6-methyladenosine regulates mRNA splicing and is required for adipogenesis. Cell Res. 2014;24(12):1403\u201319.","journal-title":"Cell Res"},{"issue":"7481","key":"16552_CR29","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1038\/nature12730","volume":"505","author":"X Wang","year":"2014","unstructured":"Wang X, Lu Z, Gomez A, Hon GC, Yue Y, Han D, Fu Y, Parisien M, Dai Q, Jia G, et al. N6-methyladenosine-dependent regulation of messenger RNA stability. Nature. 2014;505(7481):117\u201320.","journal-title":"Nature"},{"issue":"6","key":"16552_CR30","doi-asserted-by":"publisher","first-page":"1388","DOI":"10.1016\/j.cell.2015.05.014","volume":"161","author":"X Wang","year":"2015","unstructured":"Wang X, Zhao BS, Roundtree IA, Lu Z, Han D, Ma H, Weng X, Chen K, Shi H, He C. N(6)-methyladenosine Modulates Messenger RNA Translation Efficiency. Cell. 2015;161(6):1388\u201399.","journal-title":"Cell"},{"key":"16552_CR31","doi-asserted-by":"crossref","unstructured":"Li B, Zhao R, Qiu W, Pan Z, Zhao S, Qi Y, Qiu J, Zhang S, Guo Q, Fan Y et al. The N(6)-methyladenosine-mediated lncRNA WEE2-AS1 promotes glioblastoma progression by stabilizing RPN2. Theranostics. 2022;12(14):6363\u20136379.","DOI":"10.7150\/thno.74600"},{"issue":"3","key":"16552_CR32","doi-asserted-by":"publisher","first-page":"e70108","DOI":"10.1002\/mco2.70108","volume":"6","author":"Y Zhang","year":"2025","unstructured":"Zhang Y, Xie S, Li W, Gu J, Zhang XA, Ni B, Wang Z, Yang R, Song H, Zhong Y, et al. TDP-43\/ALKBH5-mediated m(6)A modification of CDC25A mRNA promotes glioblastoma growth by facilitating G1\/S cell cycle transition. MedComm (2020). 2025;6(3):e70108.","journal-title":"MedComm (2020)"},{"issue":"12","key":"16552_CR33","doi-asserted-by":"publisher","first-page":"1466","DOI":"10.1016\/j.devcel.2022.05.007","volume":"57","author":"D Lv","year":"2022","unstructured":"Lv D, Gimple RC, Zhong C, Wu Q, Yang K, Prager BC, Godugu B, Qiu Z, Zhao L, Zhang G, et al. PDGF signaling inhibits mitophagy in glioblastoma stem cells through N(6)-methyladenosine. Dev Cell. 2022;57(12):1466\u2013e14811466.","journal-title":"Dev Cell"},{"issue":"9","key":"16552_CR34","doi-asserted-by":"publisher","first-page":"e23155","DOI":"10.1096\/fj.202301343","volume":"37","author":"X Deng","year":"2023","unstructured":"Deng X, Sun X, Hu Z, Wu Y, Zhou C, Sun J, Gao X, Huang Y. Exploring the role of m6A methylation regulators in glioblastoma multiforme and their impact on the tumor immune microenvironment. FASEB J. 2023;37(9):e23155.","journal-title":"FASEB J"},{"key":"16552_CR35","doi-asserted-by":"crossref","unstructured":"Dong Z, Cui H. The Emerging Roles of RNA Modifications in Glioblastoma. Cancers (Basel). 2020;12(3):736.","DOI":"10.3390\/cancers12030736"},{"key":"16552_CR36","doi-asserted-by":"crossref","unstructured":"Zhang C, Fan X, Yang J, Zhu P. EIF3B\u2013METTL3 complex promotes cell proliferation, invasion and EGFR\/AKT signaling in cervical cancer. Oncol Rep. 2025;54(3):103.","DOI":"10.3892\/or.2025.8936"},{"key":"16552_CR37","doi-asserted-by":"crossref","unstructured":"Zhu H, Yuan P, Wu X, Huang Y, Zhang W, Sun X, Xu J, Zhou T, Xu J, Chen L et al. Endothelial USP2a-METTL16 loop potentiates IL-6 signaling via m(6)A-mediated IL-6R stabilization in pulmonary vascular remodeling. Cell Death Differ. 2026.","DOI":"10.1038\/s41418-026-01747-0"},{"issue":"9","key":"16552_CR38","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1038\/s41419-019-1846-0","volume":"10","author":"F Ma","year":"2019","unstructured":"Ma F, Li X, Ren J, Guo R, Li Y, Liu J, Sun Y, Liu Z, Jia J, Li W. Downregulation of eukaryotic translation initiation factor 3b inhibited proliferation and metastasis of gastric cancer. Cell Death Dis. 2019;10(9):623.","journal-title":"Cell Death Dis"},{"key":"16552_CR39","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1016\/j.ebiom.2019.10.030","volume":"49","author":"H Huang","year":"2019","unstructured":"Huang H, Gao Y, Liu A, Yang X, Huang F, Xu L, Danfeng X, Chen L. EIF3D promotes sunitinib resistance of renal cell carcinoma by interacting with GRP78 and inhibiting its degradation. EBioMedicine. 2019;49:189\u2013201.","journal-title":"EBioMedicine"},{"issue":"1","key":"16552_CR40","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/0006-291X(86)90239-1","volume":"138","author":"W Marsh","year":"1986","unstructured":"Marsh W, Center MS. Dimethylsulfoxide, retinoic acid and 12-O-tetradecanoylphorbol-13-acetate induce a selective decrease in the phosphorylation of P150, a surface membrane phosphoprotein of HL60 cells resistant to adriamycin. Biochem Biophys Res Commun. 1986;138(1):9\u201316.","journal-title":"Biochem Biophys Res Commun"}],"container-title":["BMC Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12885-026-16552-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-026-16552-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-026-16552-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T03:05:06Z","timestamp":1792638306000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12885-026-16552-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,27]]},"references-count":40,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["16552"],"URL":"https:\/\/doi.org\/10.1186\/s12885-026-16552-8","relation":{},"ISSN":["1471-2407"],"issn-type":[{"value":"1471-2407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,27]]},"assertion":[{"value":"14 April 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 July 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The patient data we used were acquired from publicly available datasets that were collected with patients\u2019 informed consent. Users can download relevant data for free for research and publish relevant articles. Our study is based on open-source data; there are no ethical issues or other conflicts of interest.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"1270"}}